| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |